NCT06926283 2025-09-17A Study of DXC008 in Patients With Prostate Cancer and Other Solid TumorsHangzhou DAC Biotechnology Co., Ltd.Phase 1 Recruiting110 enrolled
NCT05605522 2025-08-24A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours3B Pharmaceuticals GmbHPhase 1 Terminated19 enrolled
NCT02085148 2024-04-22A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyBayerPhase 1 Completed62 enrolled
NCT02982941 2022-02-08Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsMacroGenicsPhase 1 Completed25 enrolled
NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT01169584 2016-01-21Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsSillaJen, Inc.Phase 1 Completed6 enrolled
NCT01598454 2015-07-29Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated GangliosidesLaboratorio Elea Phoenix S.A.Phase 1 Completed15 enrolled
NCT00314925 2010-02-25Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesNeotropixPhase 1 Unknown60 enrolled